Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth M Swisher

Showing results (31-40 of 194) with videos related to

Pageof 20
Sort By:
Human Pathology|January 30, 2007
Alternate molecular genetic pathways in ovarian carcinomas of common histological typesJulia Willner, Kaitlyn Wurz, Kimberly H Allison, et al.
Molecular Cancer|July 16, 2009
Methylation and protein expression of DNA repair genes: association with chemotherapy exposure and survival in sporadic ovarian and peritoneal carcinomasElizabeth M Swisher, Rachel M Gonzalez, Toshiyasu Taniguchi, et al.
Gynecologic Oncology|December 13, 2005
Weekly gemcitabine and cisplatin in combination with pelvic radiation in the primary therapy of cervical cancer: a phase I trial of the Puget Sound Oncology Consortium, Elizabeth M Swisher, Ron E Swensen, et al.
JCO Global Oncology|May 29, 2025
Impact of Global Enrollment on Race, Ethnicity, and Age Representation in Pivotal Gynecologic Cancer Trials Leading to US Food and Drug Administration Drug ApprovalsMaheen H Khan, Kristen R Ibanez, Courtney Bowen, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Diverse Patterns of Allele-Specific Expression in Healthy Human TissuesBlaise L Mariner, Bryan Sands, Soo Yun, et al.
Translational Oncology|September 1, 2012
Angiogenic alterations associated with circulating neoplastic DNA in ovarian carcinomaTilley Jenkins Vogel, Christiana Dellorusso, Piri Welcsh, et al.
Genes, Chromosomes & Cancer|May 13, 2010
MiR-221 and MiR-222 alterations in sporadic ovarian carcinoma: Relationship to CDKN1B, CDKNIC and overall survivalKaitlyn Wurz, Rochelle L Garcia, Barbara A Goff, et al.
Genes, Chromosomes & Cancer|December 16, 2006
Common polymorphisms in TP53 and MDM2 and the relationship to TP53 mutations and clinical outcomes in women with ovarian and peritoneal carcinomasVijaya Galic, Julia Willner, Melissa Wollan, et al.
American Journal of Obstetrics and Gynecology|September 10, 2005
Tumor-specific p53 sequences in blood and peritoneal fluid of women with epithelial ovarian cancerElizabeth M Swisher, Melissa Wollan, Sarita M Mahtani, et al.
Gynecologic Oncology|February 22, 2002
Use of complementary and alternative medicine among women with gynecologic cancersElizabeth M Swisher, David E Cohn, Barbara A Goff, et al.
Pageof 20

Showing results (31-40 of 194) with videos related to

Sort By:
Pageof 20
Human Pathology|January 30, 2007
Alternate molecular genetic pathways in ovarian carcinomas of common histological typesJulia Willner, Kaitlyn Wurz, Kimberly H Allison, et al.
Molecular Cancer|July 16, 2009
Methylation and protein expression of DNA repair genes: association with chemotherapy exposure and survival in sporadic ovarian and peritoneal carcinomasElizabeth M Swisher, Rachel M Gonzalez, Toshiyasu Taniguchi, et al.
Gynecologic Oncology|December 13, 2005
Weekly gemcitabine and cisplatin in combination with pelvic radiation in the primary therapy of cervical cancer: a phase I trial of the Puget Sound Oncology Consortium, Elizabeth M Swisher, Ron E Swensen, et al.
JCO Global Oncology|May 29, 2025
Impact of Global Enrollment on Race, Ethnicity, and Age Representation in Pivotal Gynecologic Cancer Trials Leading to US Food and Drug Administration Drug ApprovalsMaheen H Khan, Kristen R Ibanez, Courtney Bowen, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Diverse Patterns of Allele-Specific Expression in Healthy Human TissuesBlaise L Mariner, Bryan Sands, Soo Yun, et al.
Translational Oncology|September 1, 2012
Angiogenic alterations associated with circulating neoplastic DNA in ovarian carcinomaTilley Jenkins Vogel, Christiana Dellorusso, Piri Welcsh, et al.
Genes, Chromosomes & Cancer|May 13, 2010
MiR-221 and MiR-222 alterations in sporadic ovarian carcinoma: Relationship to CDKN1B, CDKNIC and overall survivalKaitlyn Wurz, Rochelle L Garcia, Barbara A Goff, et al.
Genes, Chromosomes & Cancer|December 16, 2006
Common polymorphisms in TP53 and MDM2 and the relationship to TP53 mutations and clinical outcomes in women with ovarian and peritoneal carcinomasVijaya Galic, Julia Willner, Melissa Wollan, et al.
American Journal of Obstetrics and Gynecology|September 10, 2005
Tumor-specific p53 sequences in blood and peritoneal fluid of women with epithelial ovarian cancerElizabeth M Swisher, Melissa Wollan, Sarita M Mahtani, et al.
Gynecologic Oncology|February 22, 2002
Use of complementary and alternative medicine among women with gynecologic cancersElizabeth M Swisher, David E Cohn, Barbara A Goff, et al.
Pageof 20